Kohlhoff, G, Kirwan, R and Mushtaq, S (2024) The effect of vitamin D supplementation on markers of insulin resistance in women with polycystic ovarian syndrome: a systematic review. European Journal of Nutrition. ISSN 1436-6207
|
Text
The effect of vitamin D supplementation on markers of insulin resistance in women with polycystic ovarian syndrome a systematic review.pdf - Published Version Available under License Creative Commons Attribution. Download (1MB) | Preview |
Abstract
Background Insulin resistance (IR) is a common pathology in women with polycystic ovarian syndrome (PCOS) involved in increased rates of cardiometabolic disease such as diabetes and cardiovascular disease. Low serum vitamin D is often associated with insulin resistance but there is no consensus on whether vitamin D supplementation can ameliorate markers of IR in PCOS. Objectives We assessed evidence on the effects of vitamin D supplementation (≥ 1000 IU/day), without the use of additional supplements or other pharmacological treatments known to affect IR, on markers of IR and glycemic control in women with PCOS. Design A systematic search was conducted using PubMed, Medline and Web of Science databases from January 2000 up to November 2023. Randomized controlled trials that assessed the effects of vitamin D supplementation in women with PCOS, on fasting glucose, fasting insulin, glycated haemoglobin (HbA1c) or homeostatic model assessment for insulin resistance (HOMA-IR) were included. Results 9 studies were identified. Study populations ranged from 28 to 180 participants, with mean ages ranging from 22 to 30 years. Daily vitamin D doses ranged from 1714-12,000 IU. Of the included studies, 3 reported statistically significant reductions in fasting glucose, 2 reported reductions in fasting insulin, 2 reported reductions in HOMA-IR, none reported reductions in HbA1c and 5 reported no differences in any of the relevant outcomes. Conclusions In conclusion, in RCTs of vitamin D supplementation in women with PCOS, the majority of studies do not report statistically significant improvements in fasting glucose, fasting insulin, HbA1c or HOMA-IR. However, as a minority of studies report some statistically significant results, further investigation may be warranted.
Item Type: | Article |
---|---|
Uncontrolled Keywords: | 1111 Nutrition and Dietetics; Nutrition & Dietetics |
Subjects: | R Medicine > RC Internal medicine > RC1200 Sports Medicine |
Divisions: | Sport & Exercise Sciences |
Publisher: | Springer |
SWORD Depositor: | A Symplectic |
Date Deposited: | 20 Sep 2024 16:21 |
Last Modified: | 20 Sep 2024 16:30 |
DOI or ID number: | 10.1007/s00394-024-03489-6 |
URI: | https://researchonline.ljmu.ac.uk/id/eprint/24212 |
View Item |